Akari Therapeutics
(NASDAQ:AKTX)
$1.80
-0.06[-3.23%]
At close: Mar 27
$1.80
0[0.00%]
After Hours: 4:00PM EDT
Consensus Rating1
Buy
Highest Price Target1
$4.00
Lowest Price Target1
$1.50
Consensus Price Target1
$2.75

Akari Therapeutics Stock (NASDAQ:AKTX), Analyst Ratings, Price Targets, Predictions

Akari Therapeutics PLC has a consensus price target of $2.75, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from HC Wainwright & Co. and Alliance Global Partners on December 5, 2022 and November 1, 2022. With an average price target of $2.75 between HC Wainwright & Co. and Alliance Global Partners, there's an implied 52.78% upside for Akari Therapeutics PLC from these 2 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Feb
0
0
0
0
0
Jan
0
0
0
0
0
Dec 23
0
0
0
0
0
Nov 23
0
0
0
0
0
Oct 23
0
0
0
0
0
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Alliance Global Partners

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Akari Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
12/05/2022AKTXBuy Now
Akari Therapeutics
$1.80-16.67%HC Wainwright & Co.
Sean Lee
→ $30Initiates → BuyGet Alert
11/01/2022AKTXBuy Now
Akari Therapeutics
$1.80122.22%Alliance Global Partners
James Molloy
→ $80Initiates → BuyGet Alert

FAQ

Q

What is the target price for Akari Therapeutics (AKTX)?

A

The latest price target for Akari Therapeutics (NASDAQ: AKTX) was reported by HC Wainwright & Co. on December 5, 2022. The analyst firm set a price target for $1.50 expecting AKTX to fall to within 12 months (a possible -16.67% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Akari Therapeutics (AKTX)?

A

The latest analyst rating for Akari Therapeutics (NASDAQ: AKTX) was provided by HC Wainwright & Co., and Akari Therapeutics initiated their buy rating.

Q

When was the last upgrade for Akari Therapeutics (AKTX)?

A

There is no last upgrade for Akari Therapeutics.

Q

When was the last downgrade for Akari Therapeutics (AKTX)?

A

There is no last downgrade for Akari Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Akari Therapeutics (AKTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Akari Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Akari Therapeutics was filed on December 5, 2022 so you should expect the next rating to be made available sometime around December 5, 2023.

Q

Is the Analyst Rating Akari Therapeutics (AKTX) correct?

A

While ratings are subjective and will change, the latest Akari Therapeutics (AKTX) rating was a initiated with a price target of $0.00 to $1.50. The current price Akari Therapeutics (AKTX) is trading at is $1.80, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch